SAMA: Access to Pure Play Cannabis Opportunity

Bullish on industry trends around Cannabis Sector given the "acceptance" of CBD following election. SAMA is a SPAC with an agreed target in Clever Leaves. The two are planned to merge in Q4 2020. SAMA is in the HE Long List by virtue of CLVR's potential trajectory and cost base in a massively growing market. While difficult to assess price behaviour given structure, de-SPACing has led to significant price moves where the underlying entity has attractive fundamentals in place (i.e MP and EOSE).